Compounds > rubitecan
Page last updated: 2024-08-24

rubitecan and Carcinoma, Non-Small Cell Lung

rubitecan has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baka, S; Danson, S; Hoogendam, I; Linton, K; Lorigan, P; Mettinger, K; Ranson, M; Thatcher, N1

Trials

1 trial(s) available for rubitecan and Carcinoma, Non-Small Cell Lung

ArticleYear
A phase II trial with RFS2000 (rubitecan) in patients with advanced non-small cell lung cancer.
    European journal of cancer (Oxford, England : 1990), 2005, Volume: 41, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Camptothecin; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis

2005